Thomas Dick
SOM Biomedical Scholar - Professor at Georgetown University
Biography
Georgetown University
Dr Dick has 20 years of experience in mycobacteriology and antimycobacterial drug discovery. Prior to his current appointments as Member at the Center for Discovery and Innovation, Hackensack Meridian Health (CDI) and Professor at Hackensack Meridian School of Medicine and Georgetown University, he was Tuberculosis (TB) disease area head at Novartis and served as Associate Professor at Rutgers and the National University of Singapore. His research focuses on the discovery of new antibiotics for the treatment of TB and lung disease caused by Non-Tuberculous Mycobacteria (NTM). At CDI he established a fully enabled TB and NTM drug discovery platform for the discovery of target-lead couples and the delivery of preclinical development candidates. The platform includes mycobacterial strain collections, a range of in vitro potency assays, and in vivo (mouse) pharmacology and efficacy models. Target deconvolution and resistance analysis complement his compound profiling capabilities. With medicinal chemistry partners from industry and academia he developed a portfolio of de novo and repositioning drug discovery projects. Dr Dick published over 150 papers in the field of discovery, mechanism of action & resistance of antibacterials with an h-index of 49.
Expertise
Mycobacteriology, Antibiotics, Resistance, Mechanism of Action, Discovery
Research Techniques
Bacteriology, Chemical Biology, Genetics, Biochemistry
Interests
TB (Tuberculosis) and NTM (Non-tuberculous-mycobacteria) Drug Discovery
Companies
- Professor Georgetown University (2020)
- Professor Hackensack Meridian School of Medicine (2019)
- Member Center for Discovery and Innovation (2019)
- Toh Chin Chye Visiting Professor National University of Singapore (2017 — 2020)
- Associate Professor & Director Antimicrobial Drug Discovery Rutgers University (2017 — 2019)
- Associate Professor & Director BSL3 Core Facility National University of Singapore (2011 — 2017)
- Head Tuberculosis Unit Novartis (2003 — 2011)
- Principal Investigator - Mycobacteriology lab A*STAR - Agency for Science, Technology and Research (1996 — 2003)
- Postdoctoral Research Fellow A*STAR - Agency for Science, Technology and Research (1990 — 1996)
Education
- PhD Heidelberg University (1981 — 1990)
- Abitur / A level Helmholtz Gymnasium Heidelberg (1972 — 1981)
Read about executive education
Other experts
Popular Courses
Leading People and Teams
ESMT
Berlin, Germany
May 28
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Looking for an expert?
Contact us and we'll find the best option for you.